Diacylglycerol acyltransferase inhibitors

US8058299B2 · kind B2 · utility

Assignee

• VIA Pharmaceuticals, Inc. · US

Inventors

• David Robert Bolin · Montclair, US
• Adrian Wai-Hing Cheung · Glen Rock, US
• Fariborz Firooznia · Madison, US
• Matthew Hamilton · Hackettstown, US
• Lee Apostle McDermott · Sayreville, US
• Yimin Qian · Plainsboro, US
• Jenny Tan · New Providence, US
• Weiya Yun · Richmond, US

Key dates

• Filing date: May 1, 2008
• Grant date: Nov 15, 2011
• Expiry date: Jun 16, 2029

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/14
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Provided herein are compounds of the formula (I):as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity, type II diabetes mellitus and metabolic syndrome.